相关实验视频
Updated: Jun 17, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.4K
多系统缩的流行病学和临床特征:西班牙纳瓦拉的一个基于人口的研究
M E Erro1,2,3, P Arrondo4, I Gastón5,6
1Department of Neurology, Hospital Universitario de Navarra, C/Irunlarrea 3, 31008, Pamplona, Navarra, Spain. elena.erro.aguirre@cfnavarra.es.
Journal of neurology
|August 13, 2024
概括
在西班牙,多系统缩 (MSA) 的发病率很低,十年平均值为0.49/100,000人/年. 诊断需要36个月的中位数,生存率是7年后发病.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 多系统缩 (MSA) 的流行病学数据有限.
- 本研究通过分析纳瓦拉,西班牙的发病率,流行率,存活率和诊断时间来解决MSA研究的稀缺性.
研究的目的:
- 为了确定纳瓦拉州MSA的10年发病率和点患病率.
- 分析MSA患者的生存率和诊断时间.
- 为医疗保健资源管理提供关键的流行病学数据.
主要方法:
- 从2012年到2021年进行的基于人口的观察性回顾性研究.
- 纳入标准:符合最新的运动障碍学会对MSA的标准.
- 从各种健康信息来源通过医疗记录验证数据.
主要成果:
- 粗略平均年发病率 (IR) 为0.49/100,000人/年,在60-69岁年龄组达到峰值.
- 2021年12月的点患病率为2.43 / 10万人.
- 临床发病后的中位生存时间为7年;70岁以上的发病和自主发病与减少的生存时间相关. 诊断的中位时间为36个月.
结论:
- 这是西班牙首次对MSA进行基于人口的流行病学研究.
- 这些发现提供了MSA的详细发病率和流行率数据.
- 这些数据可以为MSA患者的医疗资源有效管理提供信息.
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Myasthenia Gravis: Diagnostic Tests
714
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
714
Autoimmune Disorders
398
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
398
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Parkinson's Disease: Overview
501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501
Narcolepsy
96
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
96

